| |
|
|
|
GlobalCompliancePanel, Online Training, 161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA
2013-12-09
Overview: This webinar will present an exploration of trends that are leading to adoption of e-consent; options are available for e-consent, what is involved in implementing e-consent. A live demonstration of an e-consent will set the stage for implementation questions.
Why Should You Attend : Why are you considering e-consent:
Lack of patient interest in trial participation
Need for greater patient involvement during trial
Need to explain complex terms and protocol
Need to implement remote monitoring
What concerns you the most:
Reaction of the IRB
FDA non-acceptance of the consents
Patient inability to use technology
Lack of acceptance by clinical staff
Cost
Timelines
Areas Covered in the Session
Using an e-consent to assist low literacy patient populations understand your trial
Using e-consent to assist patients in understanding their role in a complex clinical trial.
Working with an IRB in the review of a e-consent
Understanding the cost drivers of an e-consent process
Features of an e-consent. Deciding what is important to your trial.
Who Will Benefit: Clinical trial Innovation teams
VP, Clinical trials
Clinical Operations (VP, Senior Managers, Trial Managers)
IT innovation leads
Managers, VPs Research Portfolios
|
|
|
|
|
|
|
|
Organized by:
|
|
GlobalCompliancePanel |
|
|
Invited Speakers:
|
|
Dr. Brink co-founded ConsentSolutions, Inc. in 2006 to further the development of media-based approaches to informed consent for clinical trials. She is the CEO and President. The company grew out of Phase II SBIR NCI funding for the development of an online informed consent process for clinical trials, on which she was the PI. Dr. Brink has authored articles in peer-reviewed publications discussing the effect of media on the patient experience, the need for e-consent, and the pathways to implementation of electronic informed consent in clinical trials. She has conducted research and reported on patient decision-making processes, and patient knowledge outcomes when using e-consent compared to a paper-based consent. Dr. Brink has presented on electronic informed consent at DIA, DIACanada, PRIMR, ACRP, NIH and SoCRA, focusing on the benefits for patients, clinical sites and sponsors.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2013-12-09
|
|
|
|
|
|
|
|
Registration:
|
|
Contact Information: NetZealous LLC, DBA GlobalCompliancePanel 161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA USA Phone:800-447-9407 Fax: 302-288-6884 webinars@globalcompliancepanel.com http://www.globalcompliancepanel.com
|
|
|
E-mail:
|
|
support@globalcompliancepanel.com
|
|
|
|
|
|
|
|
|